136 related articles for article (PubMed ID: 31016655)
1. Transcriptomic Analysis of Cholestatic Compounds In Vitro.
Parmentier C; Couttet P; Uteng M; Wolf A; Richert L
Methods Mol Biol; 2019; 1981():175-186. PubMed ID: 31016655
[TBL] [Abstract][Full Text] [Related]
2. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
4. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
[TBL] [Abstract][Full Text] [Related]
5. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
8. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
9. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
Jackson JP; Brouwer KR
Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
11. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
Ramaiahgari SC; Ferguson SS
Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
[TBL] [Abstract][Full Text] [Related]
12. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Assay System to Detect Drug-Induced Bile Acid-Dependent Cytotoxicity Using Hepatocytes.
Takemura A; Ito K
Methods Mol Biol; 2022; 2544():119-127. PubMed ID: 36125714
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
[TBL] [Abstract][Full Text] [Related]
15. Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.
Vatakuti S; Pennings JL; Gore E; Olinga P; Groothuis GM
Chem Res Toxicol; 2016 Mar; 29(3):342-51. PubMed ID: 26881866
[TBL] [Abstract][Full Text] [Related]
16. Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach.
Vatakuti S; Olinga P; Pennings JLA; Groothuis GMM
Arch Toxicol; 2017 Mar; 91(3):1401-1412. PubMed ID: 27344345
[TBL] [Abstract][Full Text] [Related]
17. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
[TBL] [Abstract][Full Text] [Related]
18. Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes.
Adler M; Leich E; Ellinger-Ziegelbauer H; Hewitt P; Dekant W; Rosenwald A; Mally A
Toxicology; 2014 Dec; 326():86-95. PubMed ID: 25456269
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bile canalicular network formation in rat sandwich cultured hepatocytes by drugs associated with risk of severe liver injury.
Takemura A; Izaki A; Sekine S; Ito K
Toxicol In Vitro; 2016 Sep; 35():121-30. PubMed ID: 27256767
[TBL] [Abstract][Full Text] [Related]
20. Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition.
Deharde D; Schneider C; Hiller T; Fischer N; Kegel V; Lübberstedt M; Freyer N; Hengstler JG; Andersson TB; Seehofer D; Pratschke J; Zeilinger K; Damm G
Arch Toxicol; 2016 Oct; 90(10):2497-511. PubMed ID: 27325308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
